ReviewESMO gastrointestinal oncology2026

Dynamic HER2 reassessment and precision sequencing after trastuzumab in HER2-positive advanced gastric cancer.

A Ooki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.